Lupus Science & Medicine

1. Lupus Sci Med11 Nov 2026

   Real-world discontinuation of immunosuppressive therapy after proliferative lupus nephritis: the overlooked impact of non-adherence (MASSILUP-WIN)

   Cohort studyLupus & APS

2. Lupus Sci Med9 Nov 2026

   Measurement of kidney disease in a novel multidomain treatment response measure for SLE clinical trials

   Guideline or statementLupus & APS

3. Lupus Sci Med9 Nov 2026

   Risk-stratified effectiveness of direct oral anticoagulants versus vitamin K antagonists in thrombotic antiphospholipid syndrome: a prospective cohort study

   Cohort studyLupus & APS

4. Lupus Sci Med3 Nov 2026

   Maternal and neonatal outcomes in SLE: comparison of 430 pregnancies from the French GR2 study with 1720 pregnancies from French perinatal surveys

   Cohort studyLupus & APS

5. Lupus Sci Med2 Nov 2026

   Pulmonary function, functional capacity and physical activity in patients with SLE: a cross-sectional study

   Cross-sectional studyLupus & APS

6. Lupus Sci Med2 Nov 2026

   Litifilimab reduces skin and joint disease in participants with SLE: additional results from Part A of the phase II LILAC study

   Secondary analysisLupus & APS

7. Lupus Sci Med29 Oct 2026

   Effect of upadacitinib and ABBV-599 on biomarkers in SLE: results from the phase 2 SLEek study

   Randomized controlled trialLupus & APS

8. Lupus Sci Med29 Oct 2026

   Impact of deucravacitinib on arthritis in patients with systemic lupus erythematosus: results from the phase II PAISLEY SLE study

   Secondary analysisLupus & APS

9. Lupus Sci Med28 Oct 2026

   Effect of dapagliflozin on renal response in patients with biopsy-confirmed lupus nephritis receiving stable maintenance immunosuppression and renin–angiotensin system inhibition: protocol for the multicentre randomised DAPA-LN trial

   Trial designLupus & APS

10. Lupus Sci Med26 Oct 2026

    Development and validation of the SLE Disease Activity Questionnaire (SLEDAQ)

    Diagnostic or prognostic studyLupus & APS

11. Lupus Sci Med22 Oct 2026

    Impact of pregnancy on organ damage in systemic lupus erythematosus: a multicentre study

    Research articleLupus & APS

12. Lupus Sci Med22 Oct 2026

    Systemic Immune-Inflammation Index (SII) correlates with disease activity but not with interferon-associated chemokines in SLE

    Cross-sectional studyLupus & APS

13. Lupus Sci Med30 Sep 2026

    Balancing automation and expertise: real-world evaluation of AI-assisted whole-exome sequencing in lupus-causing genes

    Diagnostic or prognostic studyLupus & APS

14. Lupus Sci Med29 Sep 2026

    Interleukin-22 reflects adverse cardiometabolic features in SLE

    Cross-sectional studyLupus & APS

15. Lupus Sci Med29 Sep 2026

    Diagnostic accuracy of the Arabic composite autonomic symptom score 31 (COMPASS-31) for detecting autonomic neuropathy in SLE: a cross-sectional validation study

    Diagnostic or prognostic studyLupus & APS

16. Lupus Sci Med29 Sep 2026

    Protein biomarkers of inflammation in women with SLE and their newborn children

    Cross-sectional studyLupus & APS

17. Lupus Sci Med24 Sep 2026

    Childhood trauma and systemic lupus erythematosus activity in Tunisian patients: exploring the mediating role of post-traumatic stress disorder

    Cross-sectional studyLupus & APS

18. Lupus Sci Med24 Sep 2026

    National trends in hospitalisation, in-hospital mortality and resource use for SLE in Spain from 2016 to 2022

    Cross-sectional studyLupus & APS

19. Lupus Sci Med23 Sep 2026

    Nursing interventions for people with systemic lupus erythematosus: a systematic review

    Meta-analysisLupus & APS

20. Lupus Sci Med23 Sep 2026

    Inhibition of STING modulates dendritic cell responses and ameliorates podocyte injury in SLE

    Mechanistic studyLupus & APS

21. Lupus Sci Med22 Sep 2026

    Evaluating the reliability and quality of lupus nephritis educational content on TikTok and Bilibili: a cross-sectional content analysis

    Cross-sectional studyLupus & APS

22. Lupus Sci Med21 Sep 2026

    Comparison of cardiac MRI features of fibrosis and strain for early cardiac dysfunction assessment in patients with systemic lupus erythematosus and Sjögren’s syndrome

    Cross-sectional studyLupus & APS

23. Lupus Sci Med21 Sep 2026

    Long-term outcomes and treatments for proliferative lupus nephritis with low-level proteinuria: a multicentre retrospective study in Japan

    Cohort studyLupus & APS

24. Lupus Sci Med17 Sep 2026

    Measurement properties of the FATIGUE-PRO in patients with SLE in real-world settings

    Diagnostic or prognostic studyLupus & APS

25. Lupus Sci Med15 Sep 2026

    Risk of stroke in SLE: a systematic review and meta-analysis

    Meta-analysisLupus & APS

26. Lupus Sci Med15 Sep 2026

    Racial differences in cardiovascular events and adverse pregnancy outcomes among pregnant individuals with SLE

    Cohort studyLupus & APS

27. Lupus Sci Med12 Sep 2026

    Long-term association of the triglyceride-glucose index with cardiovascular involvement in systemic lupus erythematosus: a retrospective cohort study

    Cohort studyLupus & APS

28. Lupus Sci Med12 Sep 2026

    Integrated metabolomics and DNA methylation signatures and their association with flare remission in SLE

    Cohort studyLupus & APS

29. Lupus Sci Med12 Sep 2026

    Identification and functional characterisation of SCO1 as a mitochondria-related biomarker in lupus nephritis

    Mechanistic studyLupus & APS

30. Lupus Sci Med12 Sep 2026

    Efficacy and safety of telitacicept combined with standard of care in patients with proliferative lupus nephritis: a real-world retrospective study

    Cohort studyLupus & APS

31. Lupus Sci Med12 Sep 2026

    Unveiling the molecular and immune heterogeneity across distinct disease activity states of systemic lupus erythematosus through integrative bulk and single-cell transcriptomics

    Mechanistic studyLupus & APS

32. Lupus Sci Med9 Sep 2026

    Discordance between disease activity and long-term outcomes in DNASE1L3 deficiency: a multicentre longitudinal cohort study

    Cohort studyPediatric

33. Lupus Sci Med3 Sep 2026

    Development and temporal validation of a clinical prediction model to identify bacterial infection in hospitalised patients with systemic lupus erythematosus

    Diagnostic or prognostic studyLupus & APS

34. Lupus Sci Med1 Sep 2026

    Seasonal 25-hydroxyvitamin D levels in new childhood-onset SLE: associations with disease activity and peripheral lymphocyte subsets

    Cohort studyPediatric

35. Lupus Sci Med1 Sep 2026

    Genetic and epigenetic determinants of relapse risk in lupus nephritis

    Cohort studyLupus & APS

36. Lupus Sci Med31 Aug 2026

    Crotonylome profiling identifies MLKL crotonylation in lupus nephritis associated with RAB1A–mTOR signalling and autophagy changes in tubular epithelial cells

    Mechanistic studyLupus & APS

37. Lupus Sci Med21 Aug 2026

    DIA proteomics of FFPE renal biopsies reveals two molecular subtypes of lupus nephritis and identifies APOL1 as candidate biomarker for stratification

    Mechanistic studyLupus & APS

38. Lupus Sci Med21 Aug 2026

    Navigating the gap: the challenge of applying treat-to-target in routine lupus care—a national perspective

    Research articleLupus & APS

39. Lupus Sci Med20 Aug 2026

    Prevalence and incidence of interstitial lung diseases in systemic lupus erythematosus: systematic review and meta-analyses

    Meta-analysisLupus & APS

40. Lupus Sci Med17 Aug 2026

    Prevalence of falls in a pooled US cohort of adults with systemic lupus erythematosus: a nested cross-sectional study

    Cross-sectional studyLupus & APS

All 423 Briefs in ExploreShowing the 40 most recently published